Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
GARDEN CITY, N.Y., Nov. 15, 2023 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ:XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. (“Beyond Cancer”)), today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in a fireside discussion and one-on-one meetings at the Piper Sandler Healthcare Conference being held November 28-30, 2023 in New York City.
Related news for (XAIR)
- Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
- 24/7 Market News Snapshot 08 September, 2025 – Beyond Air, Inc. Common Stock (NASDAQ:XAIR)
- SaaS Pivots, AI Bets, and Green Tech Grabs, with Eyes on Innovation
- MoBot alert highlights: NASDAQ: OCTO, NASDAQ: AIRE, NASDAQ: NAKA, NASDAQ: XAIR, NASDAQ: SKYQ (09/08/25 09:00 AM)
- MoBot’s Stock Market Highlights – 09/08/25 08:00 AM
